Gene editing is revolutionizing medicine, and Dr. Matthew Porteus, Professor of Pediatrics at Stanford University School of Medicine, is at the forefront of this transformation. Join us for a conversation with Dr. Porteus as he shares his insights on CRISPR technology and its potential to personalize therapies for rare genetic conditions, including sickle cell disease. Discover how this groundbreaking tool not only identifies the root causes of diseases but also paves the way for innovative treatments. As we discuss the challenges of translating gene editing into clinical practice, Dr. Porteus will highlight the ethical considerations and access issues that shape the future of healthcare. Don’t miss this opportunity to explore the promise of CRISPR and its impact on the lives of patients.
CME Information: https://stanford.cloud-cme.com/medcastepisode108
Claim CE and MOC: https://stanford.cloud-cme.com/Form.aspx?FormID=3420